4Williams PK. Smith CA. molecular regulation of apoptosis:genetic controls on cell death. Cell 1993 ;74: 777.
5Hellweg R, Hartung HD. Endogenous levels of nerve growth factor are altered in experimental diabetic neuropathy.Journal of Neuroscience Research 1990;26:258.
6Schmidt RE, Plurad SB, Modert CW et al. Experimental diabetic Sprague-Dawley rats. Lab. Invert 1983 ;49:538.
7Hellweg R, Raivich R, Hartung HD, et al. Axonal transport of endogous nerve growth factor(NGF)and NGF receptor in experimental diabetic neuropathy. Exp Neurol 1994 ; 130 ( 1 ) :24.
8Frazier WA, Hogue AR, Bradshaw RA et al. Science 1972 ; 176(4034) :482.
9Duchen LW, Anjorin A, Watkins PJ et al. Ann Intern Med1980 ;92(2) :311.
10Tuttle JB. Receptor-mediated stimulation and inhibitior of nerve growth factor secrition by vascular smmoth muscle. Exp Cell Res 1993;208:350.
4Verrotti A,Giuvi PT,Morgese G,et al.New trends in the etiopathogenesis of diabetic neuropathy[J].J Child Neurol,2001 ;16(6):389 -394.
5Yagihashi S.Pathology of diabetic neuropathy; a review from the updated literature of the last 10 years[J].Nippon Rinsho,2002 ;60suppl10:204-208.
6Quattrini C,Jeziorska M,Boulton AJ,et al.Reduced vascular endothelial growth factor expression and intra -epidermal nerve fiber loss in human diabetic neuropathy[J].Diabetes Care,2008 ;31 (1):140-145.
